BGM
Qilian International Holding Group Limited
NASDAQ: BGM · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.29
-2.33% today
Updated 2026-04-30
Market cap
$66.81M
P/E ratio
—
P/S ratio
0.24x
EPS (TTM)
$-0.29
Dividend yield
—
52W range
$0 – $17
Volume
0.3M
Qilian International Holding Group Limited (BGM) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $2.68M | $4.44M | $-580197.00 | $5.08M | $345034.00 | $12.65M | $312209.00 | $544238.00 |
| Capital expenditures | $1.53M | $1.12M | $617023.00 | $458564.00 | $3.49M | $3.26M | $3.71M | $3.93M |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | $0.00 | $0.00 | $20000.00 | $0.00 | $0.00 |
| Free cash flow | $1.15M | $3.32M | $-1.20M | $4.62M | $-3.15M | $9.40M | $-3.40M | $-3.39M |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | — | $733944.00 | — | $0.00 | — | $0.00 | $1.79M | $0.00 |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — |